Advertisement
Screener

Alector, Inc. (ALEC) Amortization of Debt Issuance Costs and Discounts

1.6 / 5 stars · 19/58 Roast Me

Alector, Inc. Amortization of Debt Issuance Costs and Discounts

Alector, Inc. (ALEC) reported Amortization of Debt Issuance Costs and Discounts of $159.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Operating Activities

us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2026-08-06

  • Alector, Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-06-30 was $81.00K, a 14.08% increase year-over-year.
  • Alector, Inc. amortization of debt issuance costs and discounts for the quarter ending 2026-03-31 was $78.00K, a 13.04% increase year-over-year.
  • Alector, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-12-31 was $78.00K.
  • Alector, Inc. amortization of debt issuance costs and discounts for the quarter ending 2025-09-30 was $75.00K.
  • Alector, Inc. amortization of debt issuance costs and discounts for fiscal 2025 was $293.00K.
Period endAmortization of Debt Issuance Costs and Discounts 3 monthAmortization of Debt Issuance Costs and Discounts 6 monthAmortization of Debt Issuance Costs and Discounts 9 monthAmortization of Debt Issuance Costs and Discounts 12 month
2026-06-30$81.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$159.00K
10-Q · filed 2026-08-06
$237.00K
derived: sum of 3 quarters · filed 2026-08-06
$312.00K
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31$78.00K
10-Q · filed 2026-05-07
$156.00K
derived: sum of 2 quarters · filed 2026-05-07
$231.00K
derived: sum of 3 quarters · filed 2026-05-07
$302.00K
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31$78.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$153.00K
derived: sum of 2 quarters · filed 2026-02-25
$224.00K
derived: sum of 3 quarters · filed 2026-08-06
$293.00K
10-K · filed 2026-02-25
2025-09-30$75.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$146.00K
derived: sum of 2 quarters · filed 2026-08-06
$215.00K
10-Q · filed 2025-11-06
2025-06-30$71.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
$140.00K
10-Q · filed 2026-08-06
2025-03-31$69.00K
10-Q · filed 2026-05-07
2024-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06
$0.00
derived: sum of 2 quarters · filed 2025-11-06
$0.00
10-Q · filed 2025-11-06
2024-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07
$0.00
10-Q · filed 2025-08-07
2024-03-31$0.00
10-Q · filed 2025-05-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
ANAVEX LIFE SCIENCES CORP. (AVXL)United States$0.218B-18.37
Protalix BioTherapeutics, Inc. (PLX)$0.221B9.87
Compass Therapeutics, Inc. (CMPX)United States$0.204B-5.35
Protara Therapeutics, Inc. (TARA)United States$0.198B-3.22
Aligos Therapeutics, Inc. (ALGS)United States$0.238B-0.47
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99